The Maternal Phenylketonuria International Study

1984-2002

Richard Koch, William Hanley, Harvey Levy, Kim Matalon, Reuben Matalon, Bobbye Rouse, Frederick Trefz, Flemming Güttler, Colleen Azen, Larry Platt, Susan Waisbren, Keith Widaman, Jiaping Ning, Eva G. Friedman, Felix De La Cruz

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Objective. The purpose of this report is to review the obstetric medical, psychological, and nutritional aspects and outcome of the women and offspring enrolled in the Maternal Phenylketonuria Study, which was established to assess the efficacy of a phenylalanine (Phe)-restricted diet in preventing the morbidity associated with this disorder. Methods. A total of 382 women with hyperphenylalaninemia (HPA) were enrolled in the study and completed 572 pregnancies. Outcome measures were analyzed with χ2, Fisher exact text, analysis of variance, t test, Wilcoxon nonparametric test, and multiple logistic regression. Outcome measures were stratified according to maternal HPA classification and the time when dietary control was achieved. Results. Optimal birth outcomes occurred when maternal blood Phe levels between 120 and 360 μmol/L were achieved by 8 to 10 weeks of gestation and maintained throughout pregnancy (trimester averages of 600 μmol/L). Mothers with mild HPA achieved similar birth outcomes as mothers who were in control preconceptually and those in control by 8 to 10 weeks of pregnancy. Conclusions. Before conception, counseling and early entrance into a prenatal care program is essential in achieving optimal fetal outcome in women with HPA. The achievement of pre- and periconceptional dietary control with a Phe-restricted diet significantly decreased morbidity in the offspring of women with HPA.

Original languageEnglish (US)
Pages (from-to)1523-1529
Number of pages7
JournalPediatrics
Volume112
Issue number6 II
StatePublished - Dec 2003

Fingerprint

Maternal Phenylketonuria
Phenylketonurias
Phenylalanine
Mothers
Pregnancy
Outcome Assessment (Health Care)
Parturition
Pregnancy Trimesters
Diet
Morbidity
Prenatal Care
Obstetrics
Counseling
Analysis of Variance
Logistic Models
Psychology

Keywords

  • Maternal phenylketonuria
  • Offspring outcome
  • Phenylalanine-restricted diet
  • Pregnancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Koch, R., Hanley, W., Levy, H., Matalon, K., Matalon, R., Rouse, B., ... De La Cruz, F. (2003). The Maternal Phenylketonuria International Study: 1984-2002. Pediatrics, 112(6 II), 1523-1529.

The Maternal Phenylketonuria International Study : 1984-2002. / Koch, Richard; Hanley, William; Levy, Harvey; Matalon, Kim; Matalon, Reuben; Rouse, Bobbye; Trefz, Frederick; Güttler, Flemming; Azen, Colleen; Platt, Larry; Waisbren, Susan; Widaman, Keith; Ning, Jiaping; Friedman, Eva G.; De La Cruz, Felix.

In: Pediatrics, Vol. 112, No. 6 II, 12.2003, p. 1523-1529.

Research output: Contribution to journalArticle

Koch, R, Hanley, W, Levy, H, Matalon, K, Matalon, R, Rouse, B, Trefz, F, Güttler, F, Azen, C, Platt, L, Waisbren, S, Widaman, K, Ning, J, Friedman, EG & De La Cruz, F 2003, 'The Maternal Phenylketonuria International Study: 1984-2002', Pediatrics, vol. 112, no. 6 II, pp. 1523-1529.
Koch R, Hanley W, Levy H, Matalon K, Matalon R, Rouse B et al. The Maternal Phenylketonuria International Study: 1984-2002. Pediatrics. 2003 Dec;112(6 II):1523-1529.
Koch, Richard ; Hanley, William ; Levy, Harvey ; Matalon, Kim ; Matalon, Reuben ; Rouse, Bobbye ; Trefz, Frederick ; Güttler, Flemming ; Azen, Colleen ; Platt, Larry ; Waisbren, Susan ; Widaman, Keith ; Ning, Jiaping ; Friedman, Eva G. ; De La Cruz, Felix. / The Maternal Phenylketonuria International Study : 1984-2002. In: Pediatrics. 2003 ; Vol. 112, No. 6 II. pp. 1523-1529.
@article{2861f4f9123b4e6da30559cbf8e05d34,
title = "The Maternal Phenylketonuria International Study: 1984-2002",
abstract = "Objective. The purpose of this report is to review the obstetric medical, psychological, and nutritional aspects and outcome of the women and offspring enrolled in the Maternal Phenylketonuria Study, which was established to assess the efficacy of a phenylalanine (Phe)-restricted diet in preventing the morbidity associated with this disorder. Methods. A total of 382 women with hyperphenylalaninemia (HPA) were enrolled in the study and completed 572 pregnancies. Outcome measures were analyzed with χ2, Fisher exact text, analysis of variance, t test, Wilcoxon nonparametric test, and multiple logistic regression. Outcome measures were stratified according to maternal HPA classification and the time when dietary control was achieved. Results. Optimal birth outcomes occurred when maternal blood Phe levels between 120 and 360 μmol/L were achieved by 8 to 10 weeks of gestation and maintained throughout pregnancy (trimester averages of 600 μmol/L). Mothers with mild HPA achieved similar birth outcomes as mothers who were in control preconceptually and those in control by 8 to 10 weeks of pregnancy. Conclusions. Before conception, counseling and early entrance into a prenatal care program is essential in achieving optimal fetal outcome in women with HPA. The achievement of pre- and periconceptional dietary control with a Phe-restricted diet significantly decreased morbidity in the offspring of women with HPA.",
keywords = "Maternal phenylketonuria, Offspring outcome, Phenylalanine-restricted diet, Pregnancy",
author = "Richard Koch and William Hanley and Harvey Levy and Kim Matalon and Reuben Matalon and Bobbye Rouse and Frederick Trefz and Flemming G{\"u}ttler and Colleen Azen and Larry Platt and Susan Waisbren and Keith Widaman and Jiaping Ning and Friedman, {Eva G.} and {De La Cruz}, Felix",
year = "2003",
month = "12",
language = "English (US)",
volume = "112",
pages = "1523--1529",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "6 II",

}

TY - JOUR

T1 - The Maternal Phenylketonuria International Study

T2 - 1984-2002

AU - Koch, Richard

AU - Hanley, William

AU - Levy, Harvey

AU - Matalon, Kim

AU - Matalon, Reuben

AU - Rouse, Bobbye

AU - Trefz, Frederick

AU - Güttler, Flemming

AU - Azen, Colleen

AU - Platt, Larry

AU - Waisbren, Susan

AU - Widaman, Keith

AU - Ning, Jiaping

AU - Friedman, Eva G.

AU - De La Cruz, Felix

PY - 2003/12

Y1 - 2003/12

N2 - Objective. The purpose of this report is to review the obstetric medical, psychological, and nutritional aspects and outcome of the women and offspring enrolled in the Maternal Phenylketonuria Study, which was established to assess the efficacy of a phenylalanine (Phe)-restricted diet in preventing the morbidity associated with this disorder. Methods. A total of 382 women with hyperphenylalaninemia (HPA) were enrolled in the study and completed 572 pregnancies. Outcome measures were analyzed with χ2, Fisher exact text, analysis of variance, t test, Wilcoxon nonparametric test, and multiple logistic regression. Outcome measures were stratified according to maternal HPA classification and the time when dietary control was achieved. Results. Optimal birth outcomes occurred when maternal blood Phe levels between 120 and 360 μmol/L were achieved by 8 to 10 weeks of gestation and maintained throughout pregnancy (trimester averages of 600 μmol/L). Mothers with mild HPA achieved similar birth outcomes as mothers who were in control preconceptually and those in control by 8 to 10 weeks of pregnancy. Conclusions. Before conception, counseling and early entrance into a prenatal care program is essential in achieving optimal fetal outcome in women with HPA. The achievement of pre- and periconceptional dietary control with a Phe-restricted diet significantly decreased morbidity in the offspring of women with HPA.

AB - Objective. The purpose of this report is to review the obstetric medical, psychological, and nutritional aspects and outcome of the women and offspring enrolled in the Maternal Phenylketonuria Study, which was established to assess the efficacy of a phenylalanine (Phe)-restricted diet in preventing the morbidity associated with this disorder. Methods. A total of 382 women with hyperphenylalaninemia (HPA) were enrolled in the study and completed 572 pregnancies. Outcome measures were analyzed with χ2, Fisher exact text, analysis of variance, t test, Wilcoxon nonparametric test, and multiple logistic regression. Outcome measures were stratified according to maternal HPA classification and the time when dietary control was achieved. Results. Optimal birth outcomes occurred when maternal blood Phe levels between 120 and 360 μmol/L were achieved by 8 to 10 weeks of gestation and maintained throughout pregnancy (trimester averages of 600 μmol/L). Mothers with mild HPA achieved similar birth outcomes as mothers who were in control preconceptually and those in control by 8 to 10 weeks of pregnancy. Conclusions. Before conception, counseling and early entrance into a prenatal care program is essential in achieving optimal fetal outcome in women with HPA. The achievement of pre- and periconceptional dietary control with a Phe-restricted diet significantly decreased morbidity in the offspring of women with HPA.

KW - Maternal phenylketonuria

KW - Offspring outcome

KW - Phenylalanine-restricted diet

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=0346124136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346124136&partnerID=8YFLogxK

M3 - Article

VL - 112

SP - 1523

EP - 1529

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 6 II

ER -